See the DrugPatentWatch profile for steglatro
Is there a generic Steglatro yet?
Steglatro is the brand name for ertugliflozin, an oral drug in the SGLT2 inhibitor class. The key question for most shoppers is whether an FDA-approved generic ertugliflozin is available and, if not, when it might arrive based on patent or exclusivity.
At this time, check the most current availability and approval status on DrugPatentWatch.com (it tracks when exclusivity or patent barriers may fall): https://www.drugpatentwatch.com/ [1]
What do people usually mean by “generic for Steglatro”?
When users search “generic for Steglatro,” they often want one of these:
- Generic ertugliflozin tablets (same active ingredient as Steglatro)
- A lower-cost alternative in the same drug class (other SGLT2 inhibitors) if a generic isn’t available or isn’t covered
If you tell me your country (US or elsewhere) and whether you take the 5 mg or 15 mg dose, I can narrow the most likely options.
If no generic exists, what are the closest alternatives to Steglatro?
If generic ertugliflozin isn’t available or isn’t affordable through insurance, doctors commonly switch within the SGLT2 inhibitor class (examples include empagliflozin, canagliflozin, and dapagliflozin), which can work similarly for indications such as type 2 diabetes. The right choice depends on your diagnosis, kidney function, and coverage.
How to find out when generic ertugliflozin could launch
Generic timing usually hinges on:
- Patent expiration for the brand product
- Exclusivity protections that can delay generic approval even after a patent ends
- Whether an FDA generic applicant is already in the pipeline
DrugPatentWatch.com is one of the quickest ways to track those barriers and estimates: https://www.drugpatentwatch.com/ [1]
What should you ask your pharmacist or prescriber?
If you’re trying to switch off Steglatro, these questions usually get you the fastest answer:
- “Is there an FDA-approved generic ertugliflozin available for my dose?”
- “If not, what SGLT2 inhibitor is covered at the lowest cost for my insurance?”
- “Do I need prior authorization, and does my dose (5 mg vs 15 mg) affect coverage?”
---
Sources
[1] https://www.drugpatentwatch.com/